Paul Mellett

Track

Insider profile

Currently holds a position at Enanta Pharmaceuticals Inc

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 47% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Senior Vice President - Finance & Administration Enanta Pharmaceuticals Inc Sept. 1, 2003 -
Paul Mellett's trades of Enanta Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-10 2024-12-06
S Sale
74,531 +20.1%
440.11
US$522,124 		74,531 +20.1% 440.11 US$522,124
2023-12-06 2023-12-05
S Sale
27,543 +33.6%
376.92
US$1,175,223 		27,543 +33.6% 376.92 US$1,175,223
2023-03-17 2023-03-15
PlS Planned sale
50,473 -48.8%
447.50
US$4,629,095 		50,473 -48.8% 447.50 US$4,629,095
2023-03-17 2023-03-15
PlS Planned sale
100 -0.1%
43.96
US$4,396 		100 -0.1% 43.96 US$4,396
2023-02-13 2023-02-09
PlS Planned sale
800 -0.9%
54.41
US$43,528 		800 -0.9% 54.41 US$43,528
2023-02-13 2023-02-09
PlS Planned sale
4,200 -4.7%
53.64
US$225,288 		4,200 -4.7% 53.64 US$225,288
2021-01-08 2021-01-08
PlS Planned sale
6,000 -8.9%
45.58
US$273,463 		6,000 -8.9% 45.58 US$273,463
2020-01-06 2020-01-02
PlS Planned sale
721 -1.8%
61.66
US$44,458 		721 -1.8% 61.66 US$44,458
2020-01-06 2020-01-02
PlS Planned sale
9,279 -18.5%
60.82
US$564,341 		9,279 -18.5% 60.82 US$564,341